The drug’s developer, Cereno Scientific, believes its oral therapy could have a major impact on the pulmonary arterial ...
A new molecular imaging technique— 18 F-FAPI PET—can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early ...
Pulmonary arterial hypertension (PAH) is a vascular remodeling disease that pathologically increases pulmonary vascular resistance. Ultimately, this leads to right ventricular failure and ...
Pulmonary arterial hypertension is a disease in which ... Serotonin can promote both pulmonary vasoconstriction and pulmonary vascular remodeling and is thought to be involved in the pathobiology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback